Skip to main content
. 2025 Sep 24;17(10):152. doi: 10.3390/neurolint17100152
rTMS repetitive transcranial magnetic stimulation
DRE Drug resistant epilepsy
FDA Food and drug administration
MRI Magnetic resonance imaging
ACh Acetycholine
AChE Acetylcholinesterase
ChAT Choline acetyltransferase
CaMK Calmodulin-dependent kinase
CREB cAMP response element binding
CRMP-2 Collapsin response mediator protein 2
MS Multiple sclerosis
GAD Generalized anxiety disorder
PTSD Post-traumatic stress disorder
BDNF Brain-derived neurotrophic factor
DMEM Dulbecco Modified Eagle’s Medium
EMEM Eagle’s Minimum Essential Medium
DMSO Dimethylsufloxide
FBS Fetal bovine serum
CNS Central nervous system
4-AP 4-aminopyridine
SLEs Seizure-like events
LTD Long term depression
MEP Motor evoked potential
PD Pharmacodynamic
PK Pharmacokinetic